Guideline-based management of asthma focuses on disease severity and choosing the
appropriate medical therapy to control symptoms and reduce the risk of exacerbations …

Asthma is a common chronic disease characterized by episodic or persistent respiratory
symptoms and airflow limitation. Asthma treatment is based on a stepwise and control-based …

GINA no longer recommends treating adults/adolescents with asthma with short-acting
bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a …

Background In adults with mild asthma, a combination of an inhaled corticosteroid with a fast-
onset long-acting β-agonist (LABA) used as reliever monotherapy reduces severe …

Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

Background Asthma exacerbations are frequent in patients with severe disease. This report
describes results from two retrospective cohort studies describing exacerbation frequency …

Asthma is a serious health problem throughout the world. During the past two decades,
many scientific advances have improved our understanding of asthma and ability to manage …

For most patients, asthma is not controlled as defined by guidelines; whether this is
achievable has not been prospectively studied. A 1-year, randomized, stratified, double …

Respiratory disorders, especially non-communicable, chronic inflammatory diseases, are
amongst the leading causes of mortality and morbidity worldwide. Respiratory diseases …

Introduction Patients with asthma typically increase short-acting β 2-agonists (SABA) use
with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse …